Neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel reduces the number of cancer-associated fibroblasts through depletion of pancreatic stroma

Tomoharu Miyashita, Hidehiro Tajima, Isamu Makino, Mitsuyoshi Okazaki, Takahisa Yamaguchi, Yoshinao Ohbatake, Sinichi Nakanuma, Hironori Hayashi, Hiroyuki Takamura, Itasu Ninomiya, Sachio Fushida, Koji Kishimoto, John Harmon, Tetsuo Ohta

Research output: Contribution to journalArticle

Abstract

Background: In this study, the effects of neoadjuvant chemotherapy (NAC) on cancer-associated fibroblasts (CAFs) in pancreatic cancer stroma were investigated. Materials and Methods: Density of a-smooth muscle actin (aSMA)-positive fibroblasts in resected surgical specimens from untreated patients, patients receiving conventional gemcitabine plus S-1 (GS), and patients receiving gemcitabine plus nab-paclitaxel (GnP) was determined by hybrid cell counting. 18F-Fluorodeoxyglucose positron-emission tomography (FDG-PET) scans and carbohydrate antigen 19-9 (CA19-9) concentrations were used to assess tumor activity before and after chemotherapy in the GnP group. Results: In this retrospective study of 65 patients, aSMA expression was reduced in the GnP group, as revealed by markedly disorganized collagen and a low density of aSMA-positive fibroblasts. There were significantly fewer aSMA-positive fibroblasts in the GnP than in the untreated and GS groups, but there was no significant difference between the latter two groups. aSMA density reflected a decrease in standardized uptake value on FDG-PET, but not CA19-9 concentration, after GnP chemotherapy. Conclusion: These data suggest that the GnP regimen induces stromal depletion, resulting in fewer CAFs.

Original languageEnglish (US)
Pages (from-to)337-343
Number of pages7
JournalAnticancer Research
Volume38
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

gemcitabine
Drug Therapy
Smooth Muscle
Actins
Fibroblasts
Positron-Emission Tomography
Carbohydrates
Antigens
130-nm albumin-bound paclitaxel
Cancer-Associated Fibroblasts
Hybrid Cells
Fluorodeoxyglucose F18
Pancreatic Neoplasms

Keywords

  • Cancer-associated fibroblast
  • Chemoresistance
  • Pancreatic cancer
  • Stroma
  • Tumor microenvironment

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel reduces the number of cancer-associated fibroblasts through depletion of pancreatic stroma. / Miyashita, Tomoharu; Tajima, Hidehiro; Makino, Isamu; Okazaki, Mitsuyoshi; Yamaguchi, Takahisa; Ohbatake, Yoshinao; Nakanuma, Sinichi; Hayashi, Hironori; Takamura, Hiroyuki; Ninomiya, Itasu; Fushida, Sachio; Kishimoto, Koji; Harmon, John; Ohta, Tetsuo.

In: Anticancer Research, Vol. 38, No. 1, 01.01.2018, p. 337-343.

Research output: Contribution to journalArticle

Miyashita, T, Tajima, H, Makino, I, Okazaki, M, Yamaguchi, T, Ohbatake, Y, Nakanuma, S, Hayashi, H, Takamura, H, Ninomiya, I, Fushida, S, Kishimoto, K, Harmon, J & Ohta, T 2018, 'Neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel reduces the number of cancer-associated fibroblasts through depletion of pancreatic stroma', Anticancer Research, vol. 38, no. 1, pp. 337-343. https://doi.org/10.21873/anticanres.12227
Miyashita, Tomoharu ; Tajima, Hidehiro ; Makino, Isamu ; Okazaki, Mitsuyoshi ; Yamaguchi, Takahisa ; Ohbatake, Yoshinao ; Nakanuma, Sinichi ; Hayashi, Hironori ; Takamura, Hiroyuki ; Ninomiya, Itasu ; Fushida, Sachio ; Kishimoto, Koji ; Harmon, John ; Ohta, Tetsuo. / Neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel reduces the number of cancer-associated fibroblasts through depletion of pancreatic stroma. In: Anticancer Research. 2018 ; Vol. 38, No. 1. pp. 337-343.
@article{6e5decab103e4b47aaccb6eade32413e,
title = "Neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel reduces the number of cancer-associated fibroblasts through depletion of pancreatic stroma",
abstract = "Background: In this study, the effects of neoadjuvant chemotherapy (NAC) on cancer-associated fibroblasts (CAFs) in pancreatic cancer stroma were investigated. Materials and Methods: Density of a-smooth muscle actin (aSMA)-positive fibroblasts in resected surgical specimens from untreated patients, patients receiving conventional gemcitabine plus S-1 (GS), and patients receiving gemcitabine plus nab-paclitaxel (GnP) was determined by hybrid cell counting. 18F-Fluorodeoxyglucose positron-emission tomography (FDG-PET) scans and carbohydrate antigen 19-9 (CA19-9) concentrations were used to assess tumor activity before and after chemotherapy in the GnP group. Results: In this retrospective study of 65 patients, aSMA expression was reduced in the GnP group, as revealed by markedly disorganized collagen and a low density of aSMA-positive fibroblasts. There were significantly fewer aSMA-positive fibroblasts in the GnP than in the untreated and GS groups, but there was no significant difference between the latter two groups. aSMA density reflected a decrease in standardized uptake value on FDG-PET, but not CA19-9 concentration, after GnP chemotherapy. Conclusion: These data suggest that the GnP regimen induces stromal depletion, resulting in fewer CAFs.",
keywords = "Cancer-associated fibroblast, Chemoresistance, Pancreatic cancer, Stroma, Tumor microenvironment",
author = "Tomoharu Miyashita and Hidehiro Tajima and Isamu Makino and Mitsuyoshi Okazaki and Takahisa Yamaguchi and Yoshinao Ohbatake and Sinichi Nakanuma and Hironori Hayashi and Hiroyuki Takamura and Itasu Ninomiya and Sachio Fushida and Koji Kishimoto and John Harmon and Tetsuo Ohta",
year = "2018",
month = "1",
day = "1",
doi = "10.21873/anticanres.12227",
language = "English (US)",
volume = "38",
pages = "337--343",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "1",

}

TY - JOUR

T1 - Neoadjuvant chemotherapy with gemcitabine plus nab-paclitaxel reduces the number of cancer-associated fibroblasts through depletion of pancreatic stroma

AU - Miyashita, Tomoharu

AU - Tajima, Hidehiro

AU - Makino, Isamu

AU - Okazaki, Mitsuyoshi

AU - Yamaguchi, Takahisa

AU - Ohbatake, Yoshinao

AU - Nakanuma, Sinichi

AU - Hayashi, Hironori

AU - Takamura, Hiroyuki

AU - Ninomiya, Itasu

AU - Fushida, Sachio

AU - Kishimoto, Koji

AU - Harmon, John

AU - Ohta, Tetsuo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: In this study, the effects of neoadjuvant chemotherapy (NAC) on cancer-associated fibroblasts (CAFs) in pancreatic cancer stroma were investigated. Materials and Methods: Density of a-smooth muscle actin (aSMA)-positive fibroblasts in resected surgical specimens from untreated patients, patients receiving conventional gemcitabine plus S-1 (GS), and patients receiving gemcitabine plus nab-paclitaxel (GnP) was determined by hybrid cell counting. 18F-Fluorodeoxyglucose positron-emission tomography (FDG-PET) scans and carbohydrate antigen 19-9 (CA19-9) concentrations were used to assess tumor activity before and after chemotherapy in the GnP group. Results: In this retrospective study of 65 patients, aSMA expression was reduced in the GnP group, as revealed by markedly disorganized collagen and a low density of aSMA-positive fibroblasts. There were significantly fewer aSMA-positive fibroblasts in the GnP than in the untreated and GS groups, but there was no significant difference between the latter two groups. aSMA density reflected a decrease in standardized uptake value on FDG-PET, but not CA19-9 concentration, after GnP chemotherapy. Conclusion: These data suggest that the GnP regimen induces stromal depletion, resulting in fewer CAFs.

AB - Background: In this study, the effects of neoadjuvant chemotherapy (NAC) on cancer-associated fibroblasts (CAFs) in pancreatic cancer stroma were investigated. Materials and Methods: Density of a-smooth muscle actin (aSMA)-positive fibroblasts in resected surgical specimens from untreated patients, patients receiving conventional gemcitabine plus S-1 (GS), and patients receiving gemcitabine plus nab-paclitaxel (GnP) was determined by hybrid cell counting. 18F-Fluorodeoxyglucose positron-emission tomography (FDG-PET) scans and carbohydrate antigen 19-9 (CA19-9) concentrations were used to assess tumor activity before and after chemotherapy in the GnP group. Results: In this retrospective study of 65 patients, aSMA expression was reduced in the GnP group, as revealed by markedly disorganized collagen and a low density of aSMA-positive fibroblasts. There were significantly fewer aSMA-positive fibroblasts in the GnP than in the untreated and GS groups, but there was no significant difference between the latter two groups. aSMA density reflected a decrease in standardized uptake value on FDG-PET, but not CA19-9 concentration, after GnP chemotherapy. Conclusion: These data suggest that the GnP regimen induces stromal depletion, resulting in fewer CAFs.

KW - Cancer-associated fibroblast

KW - Chemoresistance

KW - Pancreatic cancer

KW - Stroma

KW - Tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=85039774105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039774105&partnerID=8YFLogxK

U2 - 10.21873/anticanres.12227

DO - 10.21873/anticanres.12227

M3 - Article

VL - 38

SP - 337

EP - 343

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 1

ER -